期刊文献+
共找到44篇文章
< 1 2 3 >
每页显示 20 50 100
Oncogenic role of Tc17 cells in cervical cancer development 被引量:1
1
作者 Zun-Sheng Zhang Ying Gu +3 位作者 Bing-Gang Liu Hong Tang Yu Hua Jun Wang 《World Journal of Clinical Cases》 SCIE 2020年第1期11-19,共9页
BACKGROUND As one of the subsets of CD8+T cells,Tc17 cells have recently been identified and are characterized by the secretion of interleukin(IL)-17,which is related to inflammatory diseases.AIM To assess the status ... BACKGROUND As one of the subsets of CD8+T cells,Tc17 cells have recently been identified and are characterized by the secretion of interleukin(IL)-17,which is related to inflammatory diseases.AIM To assess the status of Tc17 cells in cervical cancer and investigate the biological function of Tc17 cells in cervical cancer development.METHODS Flow cytometry assay,immunohistochemistry,and immunofluorescence were performed to detect the levels and phenotype of Tc17 cells in blood and tumor samples from patients with cervical cancer.Prior to cell suspension culture,ELISA was carried out to measure the production of IL-6,IL-1β,IL-23,CXCL12,and IL-17 in tumor tissue supernatant and co-cultured supernatant of patients with cervical cancer.In addition,multivariate analysis was performed to identify factors associated with overall survival using the Cox proportional hazards model.RESULTS Compared with normal tissues,Tc17 cells specifically accumulated in tumor tissues of cervical cancer patients.Cancer cells produced a greater amount of IL-6,IL-1β,and IL-23,which in turn promoted Tc17 cell polarization.Unlike the traditional cytotoxic CD8^+T cells,Tc17 cells secreted IL-17,which subsequently promoted CXCL12 expression in tumor cells,eventually enhancing the proliferation and migration of tumor cells.Thus,the ratio of tumor-infiltrating Tc17 cells was highly correlated with poor clinical outcome in patients with cervical cancer.CONCLUSION Our data identified the oncogenic role of Tc17 cells in the development of cervical cancer.We propose that the ratio of Tc17 cells may be a useful index in the prognosis of patients with cervical cancer. 展开更多
关键词 Cervical cancer Tc17 cells INTERLEUKIN-17 cancer development Biological function Oncogenic role
暂未订购
Chronic stress in cancer development and progression
2
作者 Xin Niu Ting Wu +4 位作者 Linghui Zeng Fangwei Wang Weiguo Lv Long Zhang Fangfang Zhou 《Science Bulletin》 2025年第22期3885-3907,共23页
Short-term stress positively affects homeostasis recovery;however,long-term stress leads to various diseases.Accumulating evidence shows that cancer processes are not only related to genetics and environment but also ... Short-term stress positively affects homeostasis recovery;however,long-term stress leads to various diseases.Accumulating evidence shows that cancer processes are not only related to genetics and environment but also to chronic stress.For patients with cancer,the disease process induces prolonged psychological and physical stress,including fear and pain,which makes chronic stress common in patients.Chronic stress,in turn,regulates different components of the primary tumor and tumor microenvironment through a wide variety of stress mediators.Furthermore,studies indicate that chronic stress increases tumor burden and mortality in patients with different types of cancer,while the management of chronic stress can alleviate disease burden and extend patient survival.Therefore,a deeper understanding of the role and mechanism of chronic stress in cancer is necessary for developing new strategies for cancer treatment beyond traditional treatment approaches.Herein,we explored the different sources of chronic stress,the molecular mechanisms through which chronic stress affects cancer development and progression,and the stress mediators involved.We discussed the multiple impacts of chronic stress on cancer,as well as the currently available intervention strategies.We also highlighted the prospects and challenges of chronic stress management in the clinical treatment of cancer. 展开更多
关键词 Chronic stress Stress mediators cancer development cancer progression Intervention strategies
原文传递
Fatty acid metabolism and cancer development 被引量:1
3
作者 陈元颖 李蓬 《Science Bulletin》 SCIE EI CAS CSCD 2016年第19期1473-1479,1469,共8页
Although the type and etiology of cancers are different, pathways in glucose metabolism, pentose phosphate pathway(PPP) and glutamine metabolism have been reprogrammed in cancer cells to adapt to their rapid growth an... Although the type and etiology of cancers are different, pathways in glucose metabolism, pentose phosphate pathway(PPP) and glutamine metabolism have been reprogrammed in cancer cells to adapt to their rapid growth and proliferation. Recent research has also shown that multiple lipid metabolic pathways are altered in cancer cells.Here, we provide a brief review for the role of fatty acid metabolism in cancer development with a special focus on fatty acid uptake and de novo synthesis, triglycerides synthesis, storage and degradation. Reprogramming in fatty acid metabolism plays important roles in providing energy,macromolecules for membrane synthesis and lipid signals during cancer development. Understanding the mechanism of deregulated lipid metabolic pathways in cancer cells would reveal novel therapeutic approaches to combat cancer. 展开更多
关键词 Lipid metabolism TAG Fatty acids cancer development
原文传递
Oncogenic MORC2 in cancer development and beyond 被引量:1
4
作者 Shan Zhang Ayao Guo +4 位作者 Huan Wang Jia Liu Chenshuang Dong Junyi Ren Guiling Wang 《Genes & Diseases》 SCIE CSCD 2024年第2期861-873,共13页
Microrchidia CW-type zinc finger 2(MORC2)is a member of the MORC superfamily of nuclear proteins.Growing evidence has shown that MORC2 not only participates in gene transcription and chromatin remodeling but also play... Microrchidia CW-type zinc finger 2(MORC2)is a member of the MORC superfamily of nuclear proteins.Growing evidence has shown that MORC2 not only participates in gene transcription and chromatin remodeling but also plays a key in human disease and tumor development by regulating the expression of downstream oncogenes or tumor suppressors.The present review provides an updated overview of MORC2 in the aspect of cancer hallmark and therapeutic resistance and summarizes its upstream regulators and downstream target genes.This systematic review may provide a favorable theoretical basis for emerging players of MORC2 in tumor development and new insight into the potential clinical application of basic science discoveries in the future. 展开更多
关键词 cancer development Hallmarks of cancer MORC2 Therapeutic target Treatment resistance
原文传递
Gut microbiota and immune alteration in cancer development:implication for immunotherapy 被引量:1
5
作者 Harry Cheuk Hay Lau Xiang Zhang Jun Yu 《eGastroenterology》 2023年第1期33-38,共6页
Human gastrointestinal tract harbours trillions of microbes to form the gut microbiota.Through interacting with host cells,gut microbes play critical roles in host physiology and function.On the other hand,an altered ... Human gastrointestinal tract harbours trillions of microbes to form the gut microbiota.Through interacting with host cells,gut microbes play critical roles in host physiology and function.On the other hand,an altered or dysbiotic microbiota is now well acknowledged for contributing to cancer development and progression.Since the last decade,immunotherapy has risen as a promising and novel means to fight against cancer.Meanwhile,accumulating studies have clearly revealed the close association of gut microbiota with immunotherapy efficacy,suggesting the feasibility of modulating microbiota to improve treatment responsiveness.In this review,we present the current evidence elucidating the interplay between gut microbiota and immune system in the development of several cancers including colorectal cancer,hepatocellular carcinoma and melanoma.We also discuss how the gut microbiota impacts immune checkpoint inhibitors,one of the most common approaches of immunotherapy,and explore approaches that aim to harness the gut microbiota to improve treatment efficacy.Overall,investigations on the relationship between microbiota and cancer immunotherapy can have important clinical significance,potentially leading to the development of more potent and effective cancer therapeutics in the near future. 展开更多
关键词 immune system gut microbiotathrough hepatocellular carcinoma altered dysbiotic microbiota IMMUNOTHERAPY cancer development gut microbiota colorectal cancer
暂未订购
Breast Cancer MCF-7 Cell Spheroid Culture for Drug Discovery and Development 被引量:2
6
作者 Guangping Chen William Liu Bingfang Yan 《Journal of Cancer Therapy》 2022年第3期117-130,共14页
In vitro 3D cancer spheroids (tumoroids) exhibit a drug resistance profile similar to that found in solid tumors. 3D spheroid culture methods recreate more physiologically relevant microenvironments for cells. Therefo... In vitro 3D cancer spheroids (tumoroids) exhibit a drug resistance profile similar to that found in solid tumors. 3D spheroid culture methods recreate more physiologically relevant microenvironments for cells. Therefore, these models are more appropriate for cancer drug screening. We have recently developed a protocol for MCF-7 cell spheroid culture, and used this method to test the effects of different types of drugs on this estrogen-dependent breast cancer cell spheroid. Our results demonstrated that MCF-7 cells can grow spheroid in medium using a low attachment plate. We managed to grow one spheroid in each well, and the spheroid can grow over a month, the size of the spheroid can grow over a hundred times in volume. Our targeted drug experimental results suggest that estrogen sulfotransferase, steroid sulfatase, and G protein-coupled estrogen receptor may play critical roles in MCF-7 cell spheroid growth, while estrogen receptors α and β may not play an essential role in MCF-7 spheroid growth. Organoids are the miniatures of in vivo tissues and reiterate the in vivo microenvironment of a specific organ, best fit for the in vitro studies of diseases and drug development. Tumoroid, developed from cancer cell lines or patients’ tumor tissue, is the best in vitro model of in vivo tumors. 3D spheroid technology will be the best future method for drug development of cancers and other diseases. Our reported method can be developed clinically to develop personalized drugs when the patient’s tumor tissues are used to develop a spheroid culture for drug screening. 展开更多
关键词 MCF-7 Cell Spheroid Culture 3D Cell Culture Estrogen-Dependent Breast cancer cancer Drug development Personalized cancer Drug development
暂未订购
Roles and molecular mechanisms of physical exercise in cancer prevention and treatment 被引量:15
7
作者 Qiaoyun Wang Wenli Zhou 《Journal of Sport and Health Science》 SCIE 2021年第2期201-210,共10页
Exercise can enhance motivation to change lifestyle behaviors,improve aerobic fitness,improve physical function,control fatigue,and enhance quality of life.Studies have demonstrated the benefits to be gained from phys... Exercise can enhance motivation to change lifestyle behaviors,improve aerobic fitness,improve physical function,control fatigue,and enhance quality of life.Studies have demonstrated the benefits to be gained from physical exercise,highlighting the importance of popularizing the concept of physical exercise for individuals and making professional exercise-treatment programs available to patients with cancer.However,the correlation between physical exercise and carcinogenesis is easily overlooked,and exercise interventions are not routinely provided to patients with cancer,especially those with advanced cancer.In this article,we present a literature review of the effects of exercise on cancer development and progression and give recent evidence for the type of exercise best suited for different types of cancer and in different disease stages.Moreover,the molecular mechanisms about regulating metabolism and systemic immune function in cancer are summarized and discussed.In conclusion,physical exercise should be considered as an important intervention for preventing and treating cancer and its complications. 展开更多
关键词 cancer development cancer treatment Molecular mechanisms Physical exercis
暂未订购
Impact of microbiota-immunity axis in pancreatic cancer management
8
作者 Ilenia Bartolini Giulia Nannini +5 位作者 Matteo Risaliti Francesco Matarazzo Luca Moraldi Maria Novella Ringressi Antonio Taddei Amedeo Amedei 《World Journal of Gastroenterology》 SCIE CAS 2022年第32期4527-4539,共13页
The microbiota impact on human diseases is well-known,and a growing body of literature is providing evidence about the complex interplay between microbiotaimmune system-human physiology/pathology,including cancers.Tog... The microbiota impact on human diseases is well-known,and a growing body of literature is providing evidence about the complex interplay between microbiotaimmune system-human physiology/pathology,including cancers.Together with the defined risk factors(e.g.,smoke habits,diet,diabetes,and obesity),the oral,gut,biliary,and intrapancreatic microbiota contribute to pancreatic cancer development through different pathways including the interaction with the immune system.Unfortunately,a great majority of the pancreatic cancer patients received a diagnosis in advanced stages not amenable to be radically treated and potentially cured.Given the poor pancreatic cancer prognosis,complete knowledge of these complicated relationships could help researchers better understand the disease pathogenesis and thus provide early potential noninvasive biomarkers,new therapeutic targets,and tools for risk stratification that might result in greater therapeutic possibilities and eventually in a better and longer patient survival. 展开更多
关键词 Gastrointestinal tumors Hepatopancreatobiliary tumors Pancreatic cancer Gut microbiota DYSBIOSIS cancer development CARCINOGENESIS
暂未订购
Age distribution,polyps and rectal cancer in the Egyptian population-based cancer registry 被引量:14
9
作者 Darlene Veruttipong Amr S Soliman +5 位作者 Samuel F Gilbert Taylor S Blachley Ahmed Hablas Mohamed Ramadan Laura S Rozek Ibrahim A Seifeldin 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第30期3997-4003,共7页
AIM:To describe the clinical and epidemiologic profiles of the disease and to compare the findings with those generated from the previous hospital-based studies.METHODS:The Gharbiah cancer registry is the only populat... AIM:To describe the clinical and epidemiologic profiles of the disease and to compare the findings with those generated from the previous hospital-based studies.METHODS:The Gharbiah cancer registry is the only population-based cancer registry in Egypt since 1998.We analyzed the data of all colorectal cancer patients included in the registry for the period of 1999-2007.All medical records of the 1364 patients diagnosed in Gharbiah during the study period were retrieved and the following information abstracted:age,residence,diagnosis date,grade,stage,topology,clinical characteristics,and histology variables.Egyptian census data for 1996 and 2006 were used to provide the general population's statistics on age,sex,residence and other related demographic factors.In addition to age-and sex-specific incidence rate analyses,we analyze the data to explore the incidence distribution by rural-urban differences among the 8 districts of the province.We also compared the incidence rates of Gharbiah to the rates of the Surveillance Epidemiology and End Results(SEER) data of the United States.RESULTS:Over the 9 year-period,1364 colorectal cancer cases were included.The disease incidence under age 40 years was relatively high(1.3/10 5) while the incidence in the age groups 40 and over was very low(12.0/10 5,19.4/10 5 and 21.2/10 5 in the age groups 40-59 years,60-69 years and > 70 years,respectively).The vast majority of tumors(97.2%) had no polyps and 37.2% of the patients presented with primary lesions in the rectum.Colorectal cancer was more common in patients from urban(55%) than rural(45%) areas.Regional differences in colon and rectal cancer incidence in the 8 districts of the study province may reflect different etiologic patterns in this population.The registry data of Egypt shows a slightly higher incidence of colorectal cancer than the United States in subjects under age 40 years.The results also shows significantly lower incidence of colorectal cancer in subjects over age 40 years compared to the same age group in the United States SEER.CONCLUSION:Low rate of polyps,low incidence in older subjects,and high rate of rectal cancer in Egypt.Future studies should explore clinical and molecular disease patterns. 展开更多
关键词 Colorectal cancer Young-onset Polyps Developing countries Egypt
暂未订购
Chinese Doctor Develops Effective Cancer Treatment
10
《China Today》 1999年第12期57-58,共2页
关键词 BRM In Chinese Doctor Develops Effective cancer Treatment
暂未订购
原发性肝癌患者介入治疗后护理依赖发展轨迹潜在类别及其影响因素
11
作者 肖璐璐 《实用临床医学(江西)》 2025年第6期97-101,共5页
目的分析原发性肝癌患者介入治疗后护理依赖发展轨迹的潜在类别及其影响因素。方法选取2021年6月至2024年7月于吉安市中心人民医院行介入治疗的原发性肝癌患者190例作为研究对象,收集患者一般资料。于出院时、出院后第1、3、6个月时,使... 目的分析原发性肝癌患者介入治疗后护理依赖发展轨迹的潜在类别及其影响因素。方法选取2021年6月至2024年7月于吉安市中心人民医院行介入治疗的原发性肝癌患者190例作为研究对象,收集患者一般资料。于出院时、出院后第1、3、6个月时,使用护理依赖量表(CDS)评估护理依赖程度并分析护理依赖轨迹的潜在类别,使用患者健康问卷(PHQ-9)评估抑郁症状严重程度,使用广泛性焦虑量表(GAD-7)评估焦虑严重程度;采用单因素、多因素Logistic回归分析影响护理依赖轨迹潜在类别的因素。结果190例患者存在3种护理依赖发展轨迹:低依赖-高改善组(46.32%)、中依赖-中改善组(34.21%)和中依赖-下降组(19.47%)。工作状况为非在职、PHQ-9和GAD-7得分高是原发性肝癌患者介入治疗后护理依赖发展轨迹潜在类别的危险因素(P<0.05),确诊时间较短(<1年)是其保护因素(P<0.05)。结论原发性肝癌患者介入治疗后护理依赖呈现3种不同发展轨迹,其类别受工作状况、心理状态及确诊时间的影响。 展开更多
关键词 原发性肝癌 介入治疗 护理依赖 发展轨迹 影响因素
暂未订购
肺癌根治术后巩固康复期患者恐动水平发展轨迹的潜在类别及影响因素分析
12
作者 陈美玲 吴友红 +1 位作者 李艳 吴燕 《护士进修杂志》 2025年第15期1628-1635,共8页
目的探讨肺癌根治术后巩固康复期患者恐动水平发展轨迹的潜在类别,并分析其影响因素。方法采用便利抽样法,选取2022年1月—2024年1月我院收治的315例行肺癌根治术的肺癌患者为研究对象,采用一般资料调查表、视觉模拟疼痛评估表、恐动症... 目的探讨肺癌根治术后巩固康复期患者恐动水平发展轨迹的潜在类别,并分析其影响因素。方法采用便利抽样法,选取2022年1月—2024年1月我院收治的315例行肺癌根治术的肺癌患者为研究对象,采用一般资料调查表、视觉模拟疼痛评估表、恐动症评估简表、安德森症状评估量表、社会支持量表、简易疲乏量表分别在患者出院前1 d(T1)、出院后1个月(T2)、出院后3个月(T3)、出院后6个月(T4)进行问卷调查。采用潜类别增长模型识别肺癌根治术后患者恐动水平变化轨迹的潜在类别,并通过单因素分析和多分类logistic回归分析其影响因素。结果参与调查的315例行肺癌根治术患者术后巩固康复期不同时间恐动水平总体呈下降趋势。肺癌根治术后患者巩固康复期阶段恐动水平分为3种不同的变化轨迹:轻度恐动组(C1组)35例(11.11%)、中恐动水平下降组(C2组)152例(48.25%)和高恐动水平下降组(C3组)128例(40.63%)。多分类logistic回归分析结果显示:以C3组为对照,年龄(OR=0.245,95%CI:0.115~0.523)、肿瘤家族史(OR=0.379,95%CI:0.180~0.797)、外科手术史(OR=0.193,95%CI:0.079~0.474)、文化程度(OR=2.723,95%CI:1.605~4.620)、TNM分期(OR=0.383,95%CI:0.215~0.685)、疼痛程度(OR=0.460,95%CI:0.292~0.726)、症状负担(OR=0.463,95%CI:0.289~0.742)、癌因性疲乏(OR=0.362,95%CI:0.221~0.593)及社会支持(OR=3.413,95%CI:1.984~5.871)均为C1组的影响因素(均P<0.05),外科手术史(OR=0.521,95%CI:0.293~0.926)及社会支持(OR=1.449,95%CI:1.011~2.076)为C2组的影响因素(均P<0.05),回归模型似然比(χ^(2)=143.872,P<0.001)。结论肺癌根治术后巩固康复期患者恐动水平发展轨迹存在3种不同的轨迹,临床工作中应密切关注高龄、低文化程度、有肿瘤家族史、既往外科手术史、TNM分期晚期及术后疼痛水平较高的患者,可通过改善患者症状负担,提升社会支持水平,降低患者癌因性疲乏,以减轻其术后恐动水平。 展开更多
关键词 肺癌根治术 术后巩固康复期 恐动症 发展轨迹 潜在类别 影响因素
暂未订购
NEDD8在胆囊癌发生发展中的作用机制研究
13
作者 魏军 周联明 蒋叶平 《南昌大学学报(医学版)》 2025年第1期21-25,30,共6页
目的探讨NEDD8在胆囊癌(GBC)中的表达情况及其对GBC细胞增殖能力的影响和作用机制。方法通过TCGA数据库分析正常人胆囊组织和GBC肿瘤样本中的NEDD8表达水平差异,使用免疫组化检测GBC组织芯片和癌旁组织芯片中的NEDD8表达水平。进行NEDD... 目的探讨NEDD8在胆囊癌(GBC)中的表达情况及其对GBC细胞增殖能力的影响和作用机制。方法通过TCGA数据库分析正常人胆囊组织和GBC肿瘤样本中的NEDD8表达水平差异,使用免疫组化检测GBC组织芯片和癌旁组织芯片中的NEDD8表达水平。进行NEDD8敲低和过表达转染以评估其对GBC细胞生长的影响(CCK-8实验和流失细胞术分别检测增殖和凋亡),并评估类泛素化过程抑制剂MLN4924对GBC细胞生长的影响。结果NEDD8在GBC组织中的表达水平高于正常胆囊组织(P<0.05),GBC组织芯片中的NEDD8表达水平高于癌旁组织芯片(P<0.05)。与对照组比较,NEDD8敲低显著抑制GBC细胞增殖并提高其凋亡率(P<0.05),而NEDD8过表达显著提高GBC细胞增殖能力并降低凋亡率(P<0.05)。MLN4924处理显著抑制GBC细胞增殖,并提高凋亡率(P<0.05)。结论NEDD8可能通过调控类泛素化通路促进GBC进展。 展开更多
关键词 胆囊癌 组织芯片 生物信息学 神经前体细胞表达的发育下调蛋白8 类泛素化修饰
暂未订购
全胃切除术和近端胃切除术治疗胃上部癌的预后分析 被引量:17
14
作者 陈红星 施祖群 董明都 《安徽医药》 CAS 2012年第10期1475-1476,共2页
目的探讨胃癌胃上部癌更为合理的手术方式。方法对该院108例胃上部癌患者施行外科手术治疗后的1、3、5年生存率及术后并发症和死亡率进行分析比较。结果第一年患者的生存率大致相同,3、5年患者的生存率及术后并发症及死亡率等方面存在... 目的探讨胃癌胃上部癌更为合理的手术方式。方法对该院108例胃上部癌患者施行外科手术治疗后的1、3、5年生存率及术后并发症和死亡率进行分析比较。结果第一年患者的生存率大致相同,3、5年患者的生存率及术后并发症及死亡率等方面存在明显差异。结论进展期胃上部癌采用全胃切除术比近端胃大部切除术更为合适。 展开更多
关键词 胃上部癌 进展期 全胃切除术 近端胃大部切除术 生存率 死亡率
暂未订购
进展期胃癌术后调强放疗联合同期化疗的初步结果 被引量:7
15
作者 韩志义 路树强 +6 位作者 杨致富 王文璋 文雨明 王幼黎 耿凤勇 高举 蔡爱兵 《中国现代医学杂志》 CAS CSCD 北大核心 2010年第8期1222-1224,共3页
目的观察进展期胃癌术后调强放疗联合同期化疗的临床效果。方法进展期胃癌根治术后患者180例,随机分为对照组和观察组各90例,对照组接受FOLFOX4方案,全部患者接受2~3周期化疗;观察组在对照组的基础上实施调强放疗,PTV边缘的处方剂量为5... 目的观察进展期胃癌术后调强放疗联合同期化疗的临床效果。方法进展期胃癌根治术后患者180例,随机分为对照组和观察组各90例,对照组接受FOLFOX4方案,全部患者接受2~3周期化疗;观察组在对照组的基础上实施调强放疗,PTV边缘的处方剂量为50 Gy。结果观察组完全缓解4例,部分缓解46例,无变化37例,进展3例,完全缓解+部分缓解占55.6%;对照组分别为2、36、44和8例,完全缓解+部分缓解占40.0%。观察组近期疗效优于对照组(P<0.05)。观察组白细胞分级:Ⅰ级34例、Ⅱ级12例、Ⅲ级7例和Ⅳ级1例;对照组分别为32例、13例、6例和2例。两组比较无显著性差异(χ2=0.67,P>0.05)。观察组发生急性放射反应4例,能够耐受。结论进展期胃癌术后实施调强放疗联合同期化疗与常规化疗相比,提高近期疗效完全缓解+部分缓解率,急性毒副反应可以耐受,可以推荐临床应用。 展开更多
关键词 进展期胃癌 手术 调强放疗 化疗
暂未订购
早期胚胎发育与肿瘤发生的相关性研究进展 被引量:7
16
作者 马延磊 秦环龙 《世界华人消化杂志》 CAS 北大核心 2008年第12期1337-1343,共7页
随着对发育生物学领域认识的不断深入,研究者发现早期胚胎发育与肿瘤发生的生物学行为存在相似之处,并且胚胎与肿瘤之间存在着重要的相互作用,为进一步从发育生物学角度去认识肿瘤,寻求治疗肿瘤开拓了新的思路.本文主要从发育生物学角... 随着对发育生物学领域认识的不断深入,研究者发现早期胚胎发育与肿瘤发生的生物学行为存在相似之处,并且胚胎与肿瘤之间存在着重要的相互作用,为进一步从发育生物学角度去认识肿瘤,寻求治疗肿瘤开拓了新的思路.本文主要从发育生物学角度阐述肿瘤的胚胎源性,早期胚胎发育与肿瘤发生在基因、蛋白、代谢水平和其它重要生物学行为方面的相似性,以及两者之间的相互作用. 展开更多
关键词 发育生物学 肿瘤 胚胎
暂未订购
基础研究与临床应用——浙江省肿瘤医院科研发展历程 被引量:2
17
作者 许沈华 毛伟敏 +4 位作者 葛明华 高永良 凌志强 林能明 高赟 《中国肿瘤》 CAS 2013年第12期975-991,共17页
全文记述浙江省肿瘤医院、浙江省肿瘤研究所的科研发展历程。多年来医院和研究所科研取得巨大进步,获得的科研成果有:①大肠癌研究建细胞系填补国内空白。②建卵巢癌模型提供研究转移理想工具。③胃癌基础与临床研究达国内外先进水平。... 全文记述浙江省肿瘤医院、浙江省肿瘤研究所的科研发展历程。多年来医院和研究所科研取得巨大进步,获得的科研成果有:①大肠癌研究建细胞系填补国内空白。②建卵巢癌模型提供研究转移理想工具。③胃癌基础与临床研究达国内外先进水平。④肺癌早期诊断和个性化治疗起示范作用。⑤头颈部恶性肿瘤转化型研究不断推进。⑥乳腺癌个体化治疗迈入分子靶向时代。⑦食管癌研究推陈出新前景辉煌。 展开更多
关键词 肿瘤医院 肿瘤研究所 科研发展
原文传递
DPPA2沉默对胃癌细胞生物学行为的影响
18
作者 徐纪伟 孙丹华 陈旭东 《现代免疫学》 CAS 北大核心 2023年第2期95-104,共10页
多能性相关基因2(developmental pluripotency-associated gene 2,DPPA2)在多能性细胞和某些癌组织中特异表达,并有望成为一些恶性肿瘤的特异性免疫治疗靶点。课题组拟研究DPPA2沉默对胃癌细胞SGC-7901生物学行为的影响,为胃癌的治疗提... 多能性相关基因2(developmental pluripotency-associated gene 2,DPPA2)在多能性细胞和某些癌组织中特异表达,并有望成为一些恶性肿瘤的特异性免疫治疗靶点。课题组拟研究DPPA2沉默对胃癌细胞SGC-7901生物学行为的影响,为胃癌的治疗提供实验依据。构建DPPA2沉默pGenesil-2/DPPA2重组载体并导入SGC-7901细胞,MTT实验、划痕实验、FACS等研究DPPA2沉默对肿瘤细胞生物学行为的影响,并建立小鼠肾被膜下移植侵袭模型研究肿瘤细胞的在体侵袭能力。结果显示,沉默DPPA2后,DPPA2、NANOG同源盒(NANOG homeobox,NANOG)和八聚体结合转录因子4(octamer binding transcription factor 4,OCT4)mRNA及蛋白表达量在SGC-7901细胞中显著降低(均P<0.01);SGC-7901细胞的增殖、迁移能力减弱,DPPA2沉默后肿瘤细胞停滞于G0/G1期,且能够促进SGC-7901细胞的凋亡;小鼠肾被膜下移植侵袭模型表明,DPPA2沉默可抑制肿瘤细胞对正常组织的局部浸润,减少肿瘤细胞对肾皮质的侵袭。结果显示,DPPA2沉默后胃癌细胞SGC-7901的生物学行为明显被抑制,表明DPPA2在促进胃癌发生、发展过程中发挥着重要的作用,沉默DPPA2可抑制NANOG、OCT4的表达,抑制肿瘤细胞对正常组织的局部浸润,达到影响胃癌细胞生物学行为的目的。 展开更多
关键词 胃癌 多能性相关基因2 基因沉默 生物学行为 质粒载体
原文传递
IFRD1基因rs3807213位点基因多态性与胃癌关系的研究
19
作者 彭昌兵 徐锐 +1 位作者 肖硕萌 庄文 《四川大学学报(医学版)》 CAS CSCD 北大核心 2014年第1期49-52,共4页
目的探讨干扰素相关发育调节蛋白1(IFRDl)基因rs3807213位点基因多态性与中国汉族人胃癌发生的关系。方法采用病例一对照研究方法,以53例胃癌患者为病例组,50例健康人为对照组。采集外周血,提取全血DNA,再采用聚合酶链反应(polym... 目的探讨干扰素相关发育调节蛋白1(IFRDl)基因rs3807213位点基因多态性与中国汉族人胃癌发生的关系。方法采用病例一对照研究方法,以53例胃癌患者为病例组,50例健康人为对照组。采集外周血,提取全血DNA,再采用聚合酶链反应(polymerase chain reaction,PCR)扩增DNA后,对IFRDl基因rs3807213位点进行测序,分析3个基因型(AA,AC,CC)在病例组和对照组之间的分布差异,并研究其与胃癌风险及临床病理分期的关系。结果病例组内rs3807213位点C等位基因频率高于对照组(OR值为3.759,95%CI为1.521~9.294;P=0.003)。与对照组相比,胃癌患者具有更高频率的rs3807213位点CC基因型(OR值为4.028,95%CI为1.513~10.720;P=0.004)。将病例组按病理分期进行分组分析,rs3807213位点各基因型及等位基因频率的组间差异均无统计学意义(P〉0.05)。结论IFRDl基因rs3807213位点基因多态性可能与中国汉族人胃癌发生有关,但与胃癌的病理分期无关。 展开更多
关键词 胃癌 干扰素相关发育调节蛋白1 基因多态性
原文传递
Ubiquitination in osteosarcoma:unveiling the impact on cell biology and therapeutic strategies
20
作者 Jianlin Shen Yue Lai +3 位作者 Yanjiao Wu Xuan Lin Cheng Zhang Huan Liu 《Cancer Biology & Medicine》 SCIE CAS CSCD 2024年第10期880-897,共18页
Ubiquitination,a multifaceted post-translational modification,regulates protein function,degradation,and gene expression.The pivotal role of ubiquitination in the pathogenesis and progression of cancer,including color... Ubiquitination,a multifaceted post-translational modification,regulates protein function,degradation,and gene expression.The pivotal role of ubiquitination in the pathogenesis and progression of cancer,including colorectal,breast,and liver cancer,is well-established.Osteosarcoma,an aggressive bone tumor predominantly affecting adolescents,also exhibits dysregulation of the ubiquitination system,encompassing both ubiquitination and deubiquitination processes.This dysregulation is now recognized as a key driver of osteosarcoma development,progression,and chemoresistance.This review highlights recent progress in elucidating how ubiquitination modulates tumor behavior across signaling pathways.We then focus on the mechanisms by which ubiquitination influences osteosarcoma cell function.Finally,we discuss the potential for targeting the ubiquitin-proteasome system in osteosarcoma therapy.By unraveling the impact of ubiquitination on osteosarcoma cell physiology,we aim to facilitate the development of novel strategies for prognosis,staging,treatment,and overcoming chemoresistance. 展开更多
关键词 UBIQUITINATION OSTEOSARCOMA cancer development therapeutic target
暂未订购
上一页 1 2 3 下一页 到第
使用帮助 返回顶部